Sorafenib Tablets 200mg
SORALIEVA contains Sorafenib, an oral multi-kinase inhibitor. It blocks multiple kinases involved in tumor cell proliferation and angiogenesis, including RAF kinases, VEGFR, and PDGFR, slowing tumor growth.
View Details
Axitinib Tablets 5 mg
AXILIEVA contains Axitinib, an oral targeted anticancer agent. It is a tyrosine kinase inhibitor (TKI) that selectively blocks vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3), inhibiting angiogenesis and tumor growth.
View Details
Sunitinib Malate Capsules 50mg
SUNITCAP 50 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing cancer progression.
View Details
Sunitinib Malate Capsules 25mg
SUNITCAP 25 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that inhibits receptors involved in tumor growth, angiogenesis, and cancer cell survival, thereby slowing disease progression.
View Details
Sunitinib Malate Capsules 12.5mg
SUNITCAP 12.5 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing disease progression.
View Details
